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Should the 14-day rule for embryo
research become the 28-day rule?
John B Appleby1 & Annelien L Bredenoord2
The “14-day rule”—broadly construed—is
used in science policy and regulation to
limit research on human embryos to a
maximum period of 14 days after their
creation or to the equivalent stage of
development that is normally attributed
to a 14-day-old embryo (Hyun et al, 2016;
Nuffield Council on Bioethics, 2017). For
several decades, the 14-day rule has been
a shining example of how science policy
and regulation can be developed with
interdisciplinary consensus and applied
across a number of countries to help fulfil
an ethical and practical purpose: to facili-
tate efficient and ethical embryo research.
However, advances in embryology and
biomedical research have led to sugges-
tions that the 14-day rule is no longer
adequate (Deglincerti et al, 2016; Shah-
bazi et al, 2016; Hurlbut et al, 2017).
Therefore, should the 14-day rule be
extended and, if so, where should we draw
a new line for permissible embryo
research? Here, we provide scientific,
regulatory and ethical arguments that the
14-day rule should be extended to 28 days
(or the developmental equivalent stage of
a 28-day-old embryo).
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Background of the 14-day rule
I n 1978, the birth of Louise Brown, theworld’s first IVF baby, marked a majorclinical breakthrough and demonstrated
that it is possible to create and sustain
human embryos in vitro. These embryos
could be used for research or to attempt a
pregnancy. In response, the Ethics Advisory
Board of the US Department of Health,
Education and Welfare held a detailed
consultation and published a report in 1979,
which cautiously supported human embryo
research. However, one of the key conditions
that the report proposed was that embryos
will not be kept alive in vitro longer than
14 days after fertilisation or the stage of
development that is equivalent to when
embryos finish implantation. At the time, it
was still a challenge to keep embryos alive
in vitro and 14 days seemed like more than
enough time to conduct research on them.
In biological terms, the 15th day of
embryo development is the point when the
primitive streak forms: that is, the beginning
of gastrulation when three layers of germ
cells differentiate. The 14th day is therefore
notable, because the embryo is then individ-
uated and can no longer become a twin.
Consequently, the 14th day has, until
recently, represented a natural and conve-
nient biological turning point at which to
restrict any further research on embryos.
When the UK assembled the Committee
of Inquiry Into Human Fertilisation and
Embryology in 1982—what became known
as the “Warnock Committee”—to debate
developments surrounding assisted concep-
tion, the idea of a 14-day limit on embryo
research was adopted as part of the Commit-
tee’s recommendations. These recommenda-
tions were published in 1984 in what is now
known as the “Warnock Report”. This 14-
day “rule” for embryo research has since
formed part of the regulations in the UK’s
Human Fertilisation and Embryology Act
1990 (as amended) until the present date,
and UK embryo research is licensed by the
Human Fertilisation and Embryology
Authority (HFEA). Since 1979, the 14-day
rule has also been upheld by the US
National Institutes of Health’s Human
Embryo Research Panel. Additionally, it has
been implemented, albeit in different ways,
by regulators and policymakers around the
world, such as in Canada, Australia, India,
Japan, the Netherlands and others (Hyun
et al, 2016); this makes the 14-day rule one
of the most internationally agreed rules in
reproductive science and medicine to date.
However, current research in the United
States and the UK has demonstrated that it is
possible to culture embryos to the equiva-
lent of 13 days and potentially longer
(Deglincerti et al, 2016; Shahbazi et al,
2016). Given that it is now within the techni-
cal reach to investigate the developmental
nature of embryos beyond 14 days, what is
science and society to make of this situation?
Should the 14-day rule be extended?
Arguments against extending the
14-day rule
Some have argued that the 14-day rule was
never meant to represent a firm moral
boundary for embryo research, but instead a
practical time limit (Hyun et al, 2016). Yet,
many would agree that since its creation,
the 14-day rule has been attributed moral
significance for a variety of reasons (Nuffield
Council on Bioethics, 2017). As a result,
some will argue that any attempt to extend
the limit for embryo research to 28 days
would be morally problematic. Therefore,
before discussing some of the reasons why it
would be beneficial to extend the 14-day
rule, we first turn to some of the arguments
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against extending it. In doing so, we assume
that any countries, groups or professional
bodies that already employ the 14-day rule
have already adopted a position that permits
or is in favour of human embryo research;
therefore, we do not focus on discussing
general arguments that reject embryo
research altogether.
Some might argue that the embryo
acquires moral standing after the 14th day,
because the onset of gastrulation signifies
that the embryo is a distinct individual and
therefore has a greater potential for person-
hood (Hyun et al, 2016). However, embryos
used for research—as opposed to attempting
a pregnancy—are already designated for
destruction at 14 days and have no potential
for personhood in these circumstances.
Therefore, it is unclear in this instance how
matters related to potential personhood are
ultimately made morally worse by delaying
the destruction of embryos for up to
28 days.
Another argument is that conducting
research on embryos after the formation of
the primitive streak risks the embryo expe-
riencing pain and suffering. In fact, the
Warnock Report viewed the 14-day rule as
a way to avoid research being carried out
on humans in development who may have
some level of sentience (Nuffield Council
on Bioethics, 2017). However, at 28 days,
no functional neural connections or sensory
systems exist in the embryo (Hurlbut et al,
2017). It is therefore impossible for the
embryo to experience sentience, pain or
suffering within this extended period of
research. While concerns related to pain
and suffering should be taken seriously, it
does not appear that they apply to our
proposed period of extended embryo
research.
Critics of our proposed extension to
28 days may also argue that it would begin
a slide down a slippery slope towards an
ever-increasing time window for embryo
research. Others may not take issue, in prin-
ciple, with extending embryo research to
28 days, but may nevertheless be concerned
that this could facilitate the further develop-
ment of technologies that they disagree with,
such as germline gene editing (Nuffield
Council on Bioethics, 2017). While it would
be disappointing if we immediately allowed
such objections to trump carefully reasoned,
well-defined and beneficial reforms to
embryo research policy, these concerns can
however be recognised as broader criticisms
of how science policy and regulations are
made and enforced in society.
The emergence of slippery slope argu-
ments in discourse surrounding scientific
research is often indicative of a broader
crisis of confidence and trust in the way
science policies, and regulations are
debated, crafted and implemented. Given
the fact that research and innovation in
reproductive biomedicine have historically
lacked robust oversight or regulation (both
within many countries and internationally),
such crises of trust and confidence should
be taken seriously and not be dismissed as
irrelevant. Therefore, any policy consulta-
tion or process of reforms regarding the
extension of the 14-day rule should be open,
transparent, informed by evidence and
should engage with the broad range of views
that surround this topic (Cavaliere, 2017).
Reasons for extending the 14-day rule
The period between the 14th and 28th day of
embryo development is sometimes referred
to as the “black box” of human development
(Hurlbut et al, 2017; Nuffield Council on
Bioethics, 2017). To date, it has been—from
a scientific or regulatory point of view—very
challenging to study and gain knowledge
about how embryos develop during this
period. However, a recent Nuffield Council
on Bioethics publication on embryo research
rightly argues that any attempt to extend the
14-day rule would need to be based at least
on the prospect of important advances in
science (Nuffield Council on Bioethics,
2017). Therefore, we outline how scientific
progress and biomedical innovation could
likely be achieved with the help of extending
the 14-day rule.
Extending the window for embryo
research to 28 days would allow scientists to
study the developmental processes during
gastrulation when the first primitive tissues
form. They could learn more about the
developing nervous system without any risk
of neural connections being present and gain
a better understanding of the early develop-
ment of organs (Hurlbut et al, 2017). It
would also be possible to advance our
knowledge about cell fate decisions during
early embryonic development (Shahbazi
et al, 2016). Moreover, an extended research
window could further improve the safety
and success rate of current IVF procedures.
For example, this could potentially help
scientists understand the nature of some
birth defects and also help clinicians predict
which IVF embryos are likely to result in a
successful pregnancy (Hurlbut et al, 2017).
Scientists could also learn more about the
physiology of pregnancy beyond the 14th
day, including the processes surrounding
implantation and why medical events such as
miscarriages happen (Hurlbut et al, 2017).
Nevertheless, a number of practical barri-
ers need to be overcome to facilitate the
study of embryos beyond 14 days. For
instance, scientists must devise and improve
ways of keeping an embryo supported and
alive in an appropriate environment (Aach
et al, 2017). This is a difficult challenge, but
may be overcome with the help of new tech-
nologies, such as 3D bioprinting and orga-
noids (Aach et al, 2017; Bredenoord et al,
2017). Indeed, extending the 14-day limit
would give researchers the opportunity to
learn how to keep embryos alive in vitro for
longer.
Benefits to research on stem cell-derived
gametes and gene editing
Scientists have also succeeded in creating
stem cell-derived gametes (SCDGs): egg and
sperm cells that have been derived in vitro
from stem cells. The potential value of
SCDGs is immense. They could be used to
create an unlimited source of male and
female gametes to potentially allow prospec-
tive parents with infertility and same-sex
couples to have children that they are genet-
ically related to. As research advances our
knowledge and capacity to create SCDGs, it
will also become possible to use these to
create embryos and study them beyond
14 days. However, before researchers can
use SCDGs to create human embryos for
assisted reproduction, it would be essential
to establish the safety and efficacy of SCDG
techniques in order to understand as much as
possible about their in vitro development—a
28-day research limit would greatly help with
this.
In addition, embryo modification using
gene editing has opened up a new frontier of
research. In the future, it might be possible
to edit genomes in order to treat genetic
diseases, such as Huntington’s disease. UK
researchers have already used CRISPR-Cas9
to edit the nuclear DNA of a human embryo
in order to study how the removal of the
OCT4 gene effects early embryo develop-
ment (Fogarty et al, 2017). While this is
groundbreaking research, it would also
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potentially be helpful to conduct research
on CRISPR-Cas9-edited embryos beyond
the 14th day of development in order to
understand the science, efficacy and
safety of these radically new technologies
(Nuffield Council on Bioethics, 2017).
Benefit to research on “synthetic”
embryos and organoids
Another scientific reason for extending
the 14-day rule is the groundbreaking
stem cell research that has made it possi-
ble to create so-called “synthetic” or stem
cell-based embryos (Aach et al, 2017)
and organoids. Human pluripotent stem
cells can be cultivated in vitro to derive-
self organising cell structures with
features that resemble early human devel-
opment (Warmflash et al, 2014; Aach
et al, 2017). These structures have been
referred to as gastruloids (Aach et al,
2017) or synthetic human entities with
embryo-like features (SHEEFs; Aach et al,
2017). While SHEEFs are not intact
embryos and are not totipotent, it may be
possible to eventually create totipotent
“synthetic embryos” (Warmflash et al,
2014; Deglincerti et al, 2016; Shahbazi
et al, 2016; Aach et al, 2017). The main
difference is that synthetic embryos would
be derived from human pluripotent stem
cells, as opposed to an egg and sperm.
Synthetic embryos could be valuable for
creating a limitless supply of research
embryos, which of course poses ethical
questions in itself, and potentially for
creating embryos for infertile persons who
wish to have children without the need to
use sperm or egg donors. Again, it will be
valuable for establishing safety and effi-
cacy, to be able to study these embryos
beyond 14 days up until the 28th day of
development.
Extending the 14-day rule on embryo
research would also benefit research on
organoids, which are three-dimensional
structures that are grown in vitro using
stem and progenitor cells (Bredenoord
et al, 2017). These miniature models of
organ tissue can form eye, brain, kidney
or intestinal tissues (among other forms) and
are valuable and versatile research tools in
biomedicine. For example, they can be used
in their own right to understand the physiol-
ogy and development of organs or as person-
alised and precise human models for drug
testing. In addition, organoids of human
tissue are often more safe, efficient and accu-
rate than animal research models, which can
help to reduce the use of animals in biomedi-
cal research. However, for the sake of safety
and accuracy, the results derived from
human organoids must be corroborated with
other research models (Bredenoord et al,
2017). By extending the 14-day rule, human
embryos could be cultured in vitro to act as
effective models for testing and verifying
organoid research findings, as embryos
begin to develop specialised cells and tissue
precursors after 14 days.
Moreover, extending the 14-day rule could
create opportunities to integrate embryo
research with organoid research. Organoids
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can potentially be used to model the specific
tissue niches that embryos use for implanta-
tion and development during pregnancy.
They could therefore be used as a “natural”
3D support structure for the development
and implantation of embryos, but also as
dynamic biological models to help scientists
understand what makes pregnancies success-
ful and what causes miscarriages (Bredeno-
ord et al, 2017). Only extending the 14-day
rule will allow researchers to combine orga-
noid and embryo research to gain this level
of in-depth insight into the early stages of
human pregnancy.
Ethics, policy and governance
Although the 14-day rule is viewed by many
as a success, it must be “fit for purpose” to
remain effective and relevant; it should not
become a dogma in itself. Science is chang-
ing and regulations need to adapt. There is
insufficient global governance of ARTs, but
the 14-day rule is one example of how
governance is widely adopted (albeit with
varying interpretations) and works well.
However, a failure to revise the 14-day rule
places the international community at risk
of losing one of its better examples of inter-
national consensus and regulation, because
the rule itself could be viewed as no longer
fit for purpose. Unwillingness by policymak-
ers to reconsider and revise the 14-day rule
would send a damaging message to both
medical innovators and those in society—
notably, patients—who stand to benefit from
research. Novel reproductive research will
require revised or new regulation (for
instance, better regulation of mitochondrial
replacement techniques, gene editing tech-
niques for embryos and SCDGs), including
an extension of the 14-day rule, in order to
transition from “bench to bedside” safely
and responsibly.
Should embryo research between day 14
and day 28 be treated with more regulatory
scrutiny than research during the first
14 days? Of course, the answer depends on
the country and its regulations. Some coun-
tries already have a rigorous regulatory
framework. For example, the UK has the
Human Fertilisation and Embryology Act
1990 (as amended) and a regulator (the
Human Fertilisation and Embryology Author-
ity—the HFEA) for licensing embryo research
within the first 14 days. Currently, the HFEA
will only permit research with a clear purpose
and it must be licensed. Such a model could
be extended to the end of the 28th day in
order to ensure rigour and consistency.
Any consultation model for amending the
14-day rule should involve discussion with
the public and a multidisciplinary array of
experts, in the form of what we have called
a modern “Reproductive Asilomar”. For
example, when implementing and reviewing
the 14-day rule, both the United States and
the UK have historically created forums to
share moral views and scientific preferences.
The inclusive nature of such regulatory
consultations has undoubtedly been respon-
sible for stronger trust in the 14-day rule and
the process that led to its implementation.
Any new consultations should therefore aim
to promote inclusivity and trust.
We have argued that there are good
reasons for extending the 14-day rule to
28 days. Allowing scientists to conduct
research on embryos could benefit science
and patients. Furthermore, in countries that
already permit embryo research until
14 days, it is difficult to identify any compel-
ling moral arguments against extending this
limit to 28 days. In order for embryo
research to fulfil its potential benefit to
humans both now and in the future, we
therefore propose that the current limit on
research should be extended to 28 days or
the equivalent developmental stage that is
normally attributed to a 28-day-old embryo.
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